Acorah Software Products - Accounts Production 15.0.600 true true 31 January 2023 1 February 2022 false true No description of principal activity 1 February 2023 31 January 2024 31 January 2024 04137635 Dr N Levine iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 04137635 2023-01-31 04137635 2024-01-31 04137635 2023-02-01 2024-01-31 04137635 frs-bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 04137635 frs-bus:FilletedAccounts 2023-02-01 2024-01-31 04137635 frs-bus:Micro-entities 2023-02-01 2024-01-31 04137635 frs-bus:EntityHasNeverTraded 2023-02-01 2024-01-31 04137635 frs-bus:AuditExempt-NoAccountantsReport 2023-02-01 2024-01-31 04137635 frs-bus:Director1 2023-02-01 2024-01-31 04137635 2022-01-31 04137635 2023-01-31 04137635 2022-02-01 2023-01-31
Registered number: 04137635
Transcapital Assets Limited
Dormant Financial Statements
For The Year Ended 31 January 2024
Halkin Lerman Davis Limited
Beaumont Chancery
44 Southampton Buildings
Holborn
London
WC2A 1AP
Balance Sheet
Registered number: 04137635
2024 2023
£ £
Current assets 100 100
NET CURRENT ASSETS 100 100
TOTAL ASSETS LESS CURRENT LIABILITIES 100 100
NET ASSETS 100 100
CAPITAL AND RESERVES 100 100

Notes

1. General Information
Transcapital Assets Limited is a private company, limited by shares, incorporated in England & Wales, registered number 04137635 . The registered office is First Floor Healthaid House, Marlborough Hill, Harrow, Middlesex, HA1 1UD.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
Dr N Levine
Director
24/09/2024